Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance

Department of Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria.
Journal of Clinical Endocrinology &amp Metabolism (Impact Factor: 6.31). 06/2008; 93(6):2307-12. DOI: 10.1210/jc.2007-2383
Source: PubMed

ABSTRACT Osteopontin (OPN) is a multifunctional protein involved in bone metabolism, cardiovascular disease, diabetes, and obesity. OPN levels are elevated in the plasma and adipose tissue of obese subjects, and are decreased with diet-induced weight loss.
We investigated the effect of bariatric surgery on plasma OPN concentrations in morbidly obese patients.
The study was performed at a university hospital.
We investigated 40 obese patients aged 43.1 +/- 1.8 yr, scheduled to undergo bariatric surgery. Roux-en-Y gastric bypass (RYGB) was performed in 30 subjects (27 females, three males), and laparoscopic adjustable gastric banding (LAGB) in 10 subjects (eight females, two males).
All patients were studied before and 1 yr (10.3-14.8 months) after the intervention.
OPN, leptin, C-reactive protein, insulin, the homeostatic model assessment insulin resistance index, calcium, 25-hydroxyvitamin D, C telopeptide, and osteocalcin were determined.
Both bariatric procedures significantly reduced body weight, body mass index, insulin, leptin, and C-reactive protein 1 yr after surgery. Plasma OPN increased from 31.4 +/- 3.8 to 52.8 +/- 3.7 ng/ml after RYGB (P < 0.001) and from 29.8 +/- 6.9 to 46.4 +/- 10.6 ng/ml after LAGB (P = 0.042). Preoperative OPN correlated with age, insulin, the homeostatic model assessment insulin resistance index, and postoperative OPN. Postoperative OPN correlated with C telopeptide and osteocalcin.
One year after RYGB and LAGB, plasma OPN levels significantly increased and correlated with biomarkers of bone turnover. Unlike other proinflammatory cytokines, OPN does not normalize but increases further after bariatric surgery.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Obesity triggers an inflammatory response characterized by elevated circulating pro-inflammatory adipokines that predisposes to T2DM and cardiovascular disease. The objective of our study was to determine apotential association of adipokine plasma profile and the presence of a MetS in obese children and adolescents compared to adults. Design and Methods: We determined serum levels of the adipokines soluble CD163 (sCD163), fetuin-A, osteopontin (OPN) and interleukin-1 receptor antagonist (IL-1 Ra) in 30 pediatric and 3 6 adult obese patients in a cross-sectional study. Results: Serum concentrations of all tested adipokines except sCD163 were significantly elevated in the pediatric cohort compared to adults. Patients with MetS showed increased serum levels of sCD163, fetuin-A and IL-1 Ra levels compared to those without MetS. Fetuin-A and sCD163 remained significantly elevated by MetS within the juvenile group and borderline significant in the adults when tested separately. In the pediatric cohort we found correlations between sCD163 and fetuin-A as well as OPN and IL-1 Ra whereas correlations of sCD163 and both fetuin-A and IL-1 Ra were found in the adult group. Conclusion: Our results indicate that adipokine profiles related to the presence of MetS significantly differ between pediatric and adult patients which may point to different underlying mechanisms.
    Experimental and Clinical Endocrinology & Diabetes 04/2014; 122(6). DOI:10.1055/s-0034-1375647 · 1.76 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bariatric surgery is the most effective therapeutic approach to morbid obesity, resulting in substantial weight loss and improved cardiometabolic profiles. However, a growing body of evidence suggests that bariatric procedures increase skeletal fragility and the risk of related future fracture secondary to excessive bone loss. Prospective evidence reveals that areal bone mineral density (aBMD) assessed by dual energy x-ray absorptiometry (DXA) declines as much as 14% in proximal femoral regions, including the femoral neck and total hip, 12-months postoperatively. Lumbar spine aBMD outcomes show greater 12-month postoperative variability across surgical procedures (−8% to +6%) and are in contrast to no change in volumetric bone mineral density (vBMD) outcomes measured by quantitative computed tomography (QCT). Diminished mechanical loading, micronutrient deficiency and malabsorption, along with neurohormonal alterations offer plausible underlying mechanisms to explain these observed post-bariatric bone changes, but most remain largely unsubstantiated in this population. Importantly, DXA-based skeletal imaging may have limited utility in accurately detecting bone change in bariatric populations, in part, because excessive tissue overlying bone increases variability of aBMD outcomes. Moreover, a paucity of fracture and osteoporosis incidence data raises questions about whether marked post-bariatric bone loss is clinically relevant or a functional adaptation to skeletal unloading. Future studies that utilize technology able to accurately capture site-specific vBMD and bone architectural changes than underpin bone strength in bariatric populations, consider mechanical load, and better quantify long-term fracture and osteoporosis incidence are necessary to understand the actual skeletal effects of bariatric surgery.
    Diabetes Obesity and Metabolism 08/2014; 16(12). DOI:10.1111/dom.12363 · 5.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity and its associated diseases are a worldwide epidemic disease. Usual weight loss cures - as diets, physical activity, behavior therapy and pharmacotherapy - have been continuously implemented but still have relatively poor long-term success and mainly scarce adherence. Bariatric surgery is to date the most effective long term treatment for morbid obesity and it has been proven to reduce obesity-related co-morbidities, among them nonalcoholic fatty liver disease, and mortality. This article summarizes such variations in gut hormones following the current metabolic surgery procedures. The profile of gut hormonal changes after bariatric surgery represents a strategy for the individuation of the most performing surgical procedures to achieve clinical results. About this topic, experts suggest that the individuation of the crosslink among the gut hormones, microbiome, the obesity and the bariatric surgery could lead to new and more specific therapeutic interventions for severe obesity and its co-morbidities, also non surgical.

Full-text (2 Sources)

Available from
Jun 2, 2014